Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;139(Suppl 3):S147-S152.
doi: 10.1542/peds.2016-1159B.

The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary

Catharine Riley  1 , Marsha Mailick  2 , Elizabeth Berry-Kravis  3   4   5 , Julie Bolen  6
Affiliations

The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary

Catharine Riley et al. Pediatrics. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: Dr Mailick is Chair of the Scientific Advisory Board of the Developmental Disabilities Program of the John Merck Fund; Dr Berry-Kravis is a member of the Scientific and Clinical Advisory Board of the National Fragile X Foundation and is the recipient of 2 current grants “Acamprosate in Fragile X Syndrome” and “GABA-mediated Mechanisms of Altered Sensory Perception in Fragile X Syndrome” from the John Merck Fund; and Drs Riley and Bolen have indicated they have no potential conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Framing a public health research agenda for FXS.
See this image and copyright information in PMC

References

    1. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65(5):905–914. - PubMed
    1. Pieretti M, Zhang FP, Fu Y-H, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66(4):817–822. - PubMed
    1. Loesch DZ, Huggins RM, Hagerman RJ. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev. 2004;10(1):31–41. - PubMed
    1. Raspa M, Wheeler A, Riley C. Public health literature review of fragile X syndrome. Pediatrics. 2017;139(S3) - PMC - PubMed
    1. Wheeler A, Raspa M, Hagerman R, Mailick M, Riley C. Implications of the FMR1 premutation for children, adolescents, adults, and their families. Pediatrics. 2017;139(S3) - PMC - PubMed

MeSH terms

Substances